District of Columbia Administrative Code

10002 USE OF A COLLABORATIVE PRACTICE AGREEMENT AND REQUIRED CONTENT 10002.1 The management of drug therapy pursuant to a collaborative practice agreement shall be initiated by an authorizing protocol that includes coverage of the patient(s) or a written referral from the license…

10003 SIGNED AUTHORIZATION 10003.1 The signatories to a collaborative practice agreement shall be a District of Columbia licensed physician involved directly in patient care where patients receive services and a District of Columbia licensed pharmacist involved directly in patien…

10004 INFORMED PATIENT CONSENT AND WITHDRAWAL OF PARTICIPATION 10004.1 Documented informed consent from the patient shall be obtained by the physician who authorizes the patient to participate in the collaborative practice agreement or by the pharmacist who is also a party to the…

10005 TERMINATION OR ALTERATION OF THE COLLABORATIVE PRACTICE AGREEMENT 10005.1 The collaborative practice agreement may be terminated at any time upon written notice by the pharmacist, physician, or the patient. Notice of termination shall be provided to all parties to the colla…

10006 APPROVAL OF PROTOCOLS OUTSIDE THE STANDARD OF CARE 10006.1 If a physician and a pharmacist intend to manage or treat a condition or disease state for which there is not a protocol that is generally accepted as the clinical standard of care, the physician and pharmacist shal…

10007 RECORDKEEPING 10007.1 Signatories to a collaborative practice agreement shall keep a copy of the agreement on file at their primary places of practice. 10007.2 The referral of a patient from the physician authorizing the implementation of drug therapy management pursuant to…

10008 DISAPPROVAL AND REVOCATION OF COLLABORATIVE PRACTICE AGREEMENTS 10008.1 The Board of Pharmacy and the Board of Medicine may disapprove or revoke a collaborative practice agreement if the Boards find: Inadequate training, experience, or education of the physician(s) or pharm…

10099 DEFINITIONS 10099.1 As used in this chapter, the following terms have the meanings ascribed: Act - the Collaborative Care Expansion Amendment Act of 2012, effective October 22, 2012 (D.C. Law 19-0185; 60 DCR 7591 (May 31, 2013)). Collaborative practice agreement- means a vo…

10099 DEFINITIONS 10099.1 As used in this chapter, the following terms have the meanings ascribed: Act - the Collaborative Care Expansion Amendment Act of 2012, effective October 22, 2012 (D.C. Law 19-0185; 60 DCR 7591 (May 31, 2013)). Collaborative practice agreement- means a vo…

10100 GENERAL PROVISIONS 10100.1 This chapter shall apply to applicants for and holders of a registration to practice as an audiology assistant. 10100.2 Chapters 40 (Health Occupations: General Rules), 41 (Health Occupations: Administrative Procedures), and 78 (Audiology) of this…

10101 TERM OF REGISTRATION 10101.1 Subject to § 10101.2, a registration issued pursuant to this chapter shall expire at 12:00 Midnight of December 31 of each even-numbered year. 10101.2 Pursuant to § 4006.3, the Director may change the renewal system and the expiration dates of r…

10102 EDUCATIONAL REQUIREMENT 10102.1 Except as otherwise provided in this chapter, to qualify for a registration to practice as an audiology assistant, an applicant shall have completed one of the following educational levels in audiology assisting, hearing sciences and disorder…

10103 WAIVER OF EDUCATIONAL REQUIREMENT 10103.1 The Board may waive the educational requirement of § 10102.1 for an applicant who: (a) Provides proof that he or she was employed as an audiology assistant under the direct supervision of an audiologist for a minimum of fifteen (15)…

10104 REGISTRATION BY ENDORSEMENT 10104.1 An applicant may be eligible for registration by endorsement if: (a) The applicant is currently licensed or registered in good standing as an audiology assistant under the laws of a state or territory of the United States pursuant to the …

10105 SCOPE OF PRACTICE 10105.1 No person may practice as an audiology assistant unless he or she is duly registered pursuant to this chapter and performs the duties of the profession under the supervision of a licensed audiologist meeting the requirements of § 10105.2. 10105.2 A…

10106 SUPERVISION OF AUDIOLOGY ASSISTANT 10106.1 The supervisor shall retain full professional and ethical responsibility for the professional conduct and performance of the audiology assistant and shall delegate duties only as commensurate with the training, experience, and abil…

10107 STANDARDS OF CONDUCT FOR AUDIOLOGY ASSISTANTS 10107.1 An audiology assistant shall adhere to the standards set forth in either the current Code of Ethics of the American Speech-Language-Hearing Association or the current Code of Ethics for the American Academy of Audiology …

10108 CONTINUING EDUCATION REQUIREMENTS 10108.1 This section shall apply to applicants for renewal, reactivation, or reinstatement of a registration and shall not apply to applicants for an initial registration or applicants seeking renewal of a registration for the first time af…

10109 APPROVED CONTINUING EDUCATION PROGRAMS AND ACTIVITIES 10109.1 A continuing education hour shall be valid and granted credit only if it is part of a program or activity approved by the Board as a program or activity that contributes to the growth of professional competence i…

10110 CONTINUING EDUCATION CREDITS 10110.1 For the purposes of this chapter, one (1) credit hour shall mean sixty (60) minutes of learning time. 10110.2 The Board may grant ten (10) continuing education hours for completion of each credit hour of an academic course offered at an …

10199 DEFINITIONS 10199.1 As used in this chapter, the following terms shall have the meanings ascribed: Approved continuing education – A continuing education program or activity that meets the requirements of § 10109. Board – The Board of Audiology and Speech-Language Pathology…

10200 GENERAL PROVISIONS 10200.1 This chapter applies to applicants for and holders of a registration to practice as a speech-language pathology assistant. 10200.2 Chapter 40 (Health Occupations: General Rules), 41 (Health Occupations: Administrative Procedures), and 79 (Speech-L…

10201 TERM OF REGISTRATION 10201.1 Subject to § 10201.2, a registration issued pursuant to this chapter shall expire at 12:00 Midnight of December 31st of each even-numbered year. 10201.2 The Director may change the renewal system and the expiration dates of registrations issued …

10202 EDUCATIONAL REQUIREMENT 10202.1 Except as otherwise provided in this chapter, to qualify for a registration to practice as a speech-language pathology assistant, an applicant shall have graduated from an accredited college or university with at least an associate’s degree f…

10203 WAIVER OF EDUCATIONAL REQUIREMENT 10203.1 The Board may waive the educational requirement of § 10202.1 for an applicant who: (a) Provides proof that he or she was employed as a speech-language pathology assistant practicing under the supervision of a speech-language patholo…

10204 REGISTRATION BY ENDORSEMENT 10204.1 An applicant for registration by endorsement may qualify for registration by endorsement if the applicant is licensed, registered, certified, or accredited by an accrediting association or a state board and recognized by the Board as a qu…

10205 SCOPE OF PRACTICE 10205.1 No person may practice as a speech-language pathology assistant unless registered in accordance with the requirements of this chapter. 10205.2 A speech-language pathology assistant may only practice under the supervision of a licensed speech-langua…

10206 STANDARDS OF CONDUCT 10206.1 A speech-language pathology assistant shall adhere to the standards set forth in the most current publication of the “Code of Ethics” as published by the American Speech-Language-Hearing Association, as it may be republished from time to time. 1…

10207 SUPERVISION OF SPEECH-LANGUAGE PATHOLOGY ASSISTANTS 10207.1 The speech-language pathologist supervising a speech-language pathology assistant shall retain full professional and ethical responsibility for the professional conduct and performance of the speech-language pathol…

10208 CONTINUING EDUCATION REQUIREMENTS 10208.1 This section shall apply to applicants for renewal, reinstatement, or reactivation of a registration and shall not apply to applicants for an initial registration or applicants seeking the renewal of a registration for the first tim…

10209 APPROVED CONTINUING EDUCATION PROGRAMS AND ACTIVITIES 10209.1 A continuing education hour shall be valid and granted credit only if it is part of a program or activity approved by the Board as a program or activity that contributes to the growth of professional competence i…

10210 CONTINUING EDUCATION CREDITS 10210.1 For the purposes of this chapter, one (1) credit hour shall mean sixty (60) minutes of learning time. 10210.2 The Board may grant ten (10) continuing education hours for completion of each credit hour of an academic course offered at an …

10299 DEFINITIONS 10299.1 As used in this chapter, the following terms shall have the meanings ascribed: Approved continuing education – A continuing education program or activity that meets the requirements of § 10209. Board – the Board of Audiology and Speech-Language Pathology…

10300 GENERAL PROVISIONS 10300.1 The Prescription Drug Monitoring Program (Program) shall employ information technology necessary for dispensers to report the prescription monitoring data set forth in § 10301.4 to the Program. 10300.2 A prescriber or dispenser: (a) Is not require…

10301 PRESCRIPTION MONITORING DATA REPORTING REQUIREMENTS 10301.1 Each dispenser of a covered substance shall submit the prescription monitoring data required in § 10301.4, in the form and manner required by § 10303, to the Program within twenty-four (24) hours after a covered su…

10302 COVERED SUBSTANCES 10302.1 Covered substances are controlled substances, as defined in this rulemaking, and the following drugs of concern: All drug products containing Cyclobenzaprine; All drug products containing Butalbital; and All drug products containing Gabapentin. SO…

10303 STANDARDS AND FORMAT FOR REPORTING 10303.1 The required prescription monitoring data subject to reporting pursuant to §§ 10301 and 10302 shall be transmitted electronically to the Program: Within twenty-four (24) hours of dispensing; In the format provided in the Electronic…

10304 ZERO REPORTING 10304.1 A dispenser that dispenses no covered substances within a twenty-four (24) hour reporting period shall submit a report documenting that zero covered substances were dispensed during that twenty-four (24) hour reporting period. 10304.2 The Program may,…

10305 CRITERIA FOR GRANTING WAIVERS OF THE REPORTING REQUIREMENTS 10305.1 The Program may grant a temporary waiver of all or some of the reporting requirements to a dispenser who files a request in writing or electronically on a form provided by the Program and who meets the crit…

10306 PRESCRIBER AND DISPENSER ACCESS TO PRESCRIPTION MONITORING DATA 10306.1 Prescribers, dispensers, and their delegates shall register with the Program in order to access or otherwise request disclosure of prescription monitoring data. 10306.2 Prescribers, dispensers, and thei…

10307 MANDATORY DISCLOSURE OF PRESCRIPTION MONITORING INFORMATION FOR LAW ENFORCEMENT AND REGULATORY PURPOSES 10307.1 To request disclosure of prescription monitoring data for law enforcement or regulatory purposes, an individual shall be registered with the Program as an authori…

10308 DISCRETIONARY DISCLOSURE OF INFORMATION 10308.1 The Director may, at the Director’s discretion, disclose prescription monitoring data in the Program’s possession as permitted by the Act to certain persons, provided the request is made in the format designated in § 10303 and…

10309 INTEROPERABILITY WITH OTHER STATE PRESCRIPTION DRUG MONITORING PROGRAMS 10309.1 Upon request, the Program may disclose prescription monitoring data to another state's prescription drug monitoring program provided that the request: (a) Is submitted on a form or in a manner a…

10310 NOTICE OF REQUESTS FOR INFORMATION 10310.1 Any prescriber or dispenser who intends to request information from the Program about a patient or prospective patient shall provide notice to the patient that a request may be made to obtain information on all covered substances d…

10311 CONFIDENTIALITY 10311.1 All prescription monitoring data collected, maintained, or submitted pursuant to this Program is confidential, privileged, not subject to discovery, subpoena, or other means of legal compulsion in civil litigation, and is not a public record. 10311.2…

10312 REQUESTS TO PROGRAM TO CORRECT PRESCRIPTION MONITORING DATA 10312.1 If a patient, a patient's authorized representative, or a prescriber believes that prescription monitoring data relating to the patient's or prescriber’s prescription history is incorrect, the patient, auth…

10316 THE PDMP ADVISORY COMMITTEE 10316.1 The PDMP Advisory Committee (“Committee”) shall consist of thirteen (13) members, eight (8) of which shall be ex officio members. The Director of the Department of Health (“Director”) shall appoint the remaining five (5) members, who may …

10399 DEFINITIONS 10399.1 The following terms shall have the meanings ascribed: Act – the Prescription Drug Monitoring Program Act of 2013, effective February 22, 2014 (D.C. Law 20-66; D.C. Official Code §§ 48-853.01 et seq.). Administer – the direct application of a controlled s…

10400 GENERAL PROVISIONS 10400.1 This chapter shall apply to persons authorized to practice athletic training and persons applying for or holding a license to practice athletic training. 10400.2 Chapters 40 (Health Occupations: General Rules) and 41 (Health Occupations: Administr…

10401 TERM OF LICENSE 10401.1 Subject to § 10401.2, a license issued pursuant to this chapter shall expire at 12:00 midnight of December 31st of each even-numbered year. 10401.2 If the Director changes the renewal system pursuant to § 4006.3 of Chapter 40 of this title, a license…